Autoimmune Diabetes Not Requiring Insulin at Diagnosis (Latent Autoimmune Diabetes of the Adult)
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Type 1 diabetes is caused by the immune-mediated destruction of islet insulin-secreting β-cells. This chronic destructive process is associated with both cellular and humoral immune changes in the peripheral blood that can be detected months or even years before the onset of clinical diabetes. Throughout this prediabetic period, metabolic changes, including altered glucose tolerance and reduced insulin secretion, deteriorate at variable rates and eventually result in clinical diabetes. A fraction of individuals with humoral immunological changes have clinical diabetes that initially is not insulin-requiring. The onset of diabetes in these patients is usually in adult life, and because their diabetes is at least initially not insulin-requiring, they appear clinically to be affected by type 2 diabetes. Such patients probably have the same disease process as patients with type 1 diabetes in that they have similar HLA genetic susceptibility as well as autoantibodies to islet antigens, low insulin secretion, and a higher rate of progression to insulin dependency. These patients are defined as being affected by an autoimmune type of diabetes not requiring insulin at diagnosis, which is also named latent autoimmune diabetes of the adult (LADA). Special attention should be paid to diagnose such patients because therapy may influence the speed of progression toward insulin dependency, and in this respect, efforts should be made to protect residual C-peptide secretion. LADA can serve as a model for designing new strategies for prevention of type 1 diabetes but also as a target group for prevention in its own right.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus
DeFronzo, R. A., & Goodman, A. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330902 · Cited by 1,368
Turner, R., Stratton, I., Horton, V., Manley, S., Zimmet, P., Mackay, I. R., Shattock, M., Bottazzo, G. F., & Holman, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03062-6 · Cited by 779
Variation and trends in incidence of childhood diabetes in Europe
(2000) · The Lancet · doi:10.1016/s0140-6736(99)07125-1 · Cited by 755
Tuomi, T., Groop, L. C., Zimmet, P. Z., Rowley, M. J., Knowles, W., & Mackay, I. R. (1993) · Diabetes · doi:10.2337/diab.42.2.359 · Cited by 581
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
Tuomi, T., Carlsson, A., Li, H., Isomaa, B., Miettinen, A., Nilsson, A., Nissén, M., Ehrnström, B. O., Forsén, B., Snickars, B., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.1.150 · Cited by 502
Oates, J. A., Wood, A. J. J., & Gerich, J. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911023211805 · Cited by 480
Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study
Skyler, J. S., Cefalu, W. T., Kourides, I. A., Landschulz, W. H., Balagtas, C. C., Cheng, S.-L., & Gelfand, R. A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03638-2 · Cited by 301
Insulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy
Atkinson, M. A., Maclaren, N. K., & Luchetta, R. (1990) · Diabetes · doi:10.2337/diab.39.8.933 · Cited by 299
Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.
Caillat-Zucman, S., Garchon, H. J., Timsit, J., Assan, R., Boitard, C., Djilali-Saiah, I., Bougnères, P., & Bach, J. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116110 · Cited by 289
A Comparison of Childhood and Adult Type I Diabetes Mellitus
Karjalainen, J., Salmela, P., Ilonen, J., Surcel, H.-M., & Knip, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201401 · Cited by 279
Banerji, M. A., Chaiken, R. L., Huey, H., Tuomi, T., Norin, A. J., Mackay, I. R., Rowley, M. J., Zimmet, P. Z., & Lebovitz, H. E. (1994) · Diabetes · doi:10.2337/diab.43.6.741 · Cited by 266
Immunogenetic and Clinical Characterization of Slowly Progressive IDDM
Kobayashi, T., Tamemoto, K., Nakanishi, K., Kato, N., Okubo, M., Kajio, H., Sugimoto, T., Murase, T., & Kosaka, K. (1993) · Diabetes Care · doi:10.2337/diacare.16.5.780 · Cited by 251
Putative environmental factors in Type 1 diabetes
Åkerblom, H. K., & Knip, M. (1998) · Diabetes / Metabolism Reviews · doi:10.1002/(sici)1099-0895(199803)14:1<31::aid-dmr201>3.0.co;2-a · Cited by 240
Komulainen, J., Kulmala, P., Savola, K., Lounamaa, R., Ilonen, J., Reijonen, H., Knip, M., & Akerblom, H. K. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.1950 · Cited by 201
Efficacy of metformin in the treatment of NIDDM. Meta-analysis.
Johansen, K. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.33 · Cited by 186
The Pathogenesis and Prevention of Diabetes in Adults: Genes, autoimmunity, and demography
Zimmet, P. Z. (1995) · Diabetes Care · doi:10.2337/diacare.18.7.1050 · Cited by 179
GAD Antibodies in NIDDM: Ten-year follow-up from the diagnosis
Niskanen, L. K., Tuomi, T., Karjalainen, J., Groop, L. C., & Uusitupa, M. I. J. (1995) · Diabetes Care · doi:10.2337/diacare.18.12.1557 · Cited by 164
Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes.
Pietropaolo, M., Barinas-Mitchell, E., Pietropaolo, S. L., Kuller, L. H., & Trucco, M. (2000) · Diabetes · doi:10.2337/diabetes.49.1.32 · Cited by 159
The Wisconsin Epidemiologic Study of Diabetic Retinopathy-Reply
Klein, R. (1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100060024016 · Cited by 154
Henry, R. R. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70267-x · Cited by 152
Seißler, J., de Sonnaville, J. J. J., Morgenthaler, N. G., Steinbrenner, H., Glawe, D., Khoo-Morgenthaler, U.-Y., Lan, M. S., Notkins, A. L., Heine, R. J., & Scherbaum, W. A. (1998) · Diabetologia · doi:10.1007/s001250051004 · Cited by 150
Kobayashi, T., Nakanishi, K., Murase, T., & Kosaka, K. (1996) · Diabetes · doi:10.2337/diab.45.5.622 · Cited by 149
Horton, V. A., STRATTON, I. M., Bottazzo, G. F., Shattock, M., Mackay, I., Zimmet, P., Manley, S. E., Holman, R. R., & Turner, R. C. (1999) · Diabetologia · doi:10.1007/s001250051202 · Cited by 122
Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA).
Isomaa, B., Almgren, P., Henricsson, M., Taskinen, M. R., Tuomi, T., Groop, L., & Sarelin, L. (1999) · Diabetes Care · doi:10.2337/diacare.22.8.1347 · Cited by 116
The Belgian Diabetes Registry, Vandewalle, C. L., Decraene, T., Schuit, F. C., Leeuw, I. H. D., PipeIeers, D. G., & Gorus, F. (1993) · Diabetologia · doi:10.1007/bf00401060 · Cited by 116
Gambelunghe, G., Forini, F., Laureti, S., Murdolo, G., Toraldo, G., Santeusanio, F., Brunetti, P., Sanjeevi, C. B., & Falorni, A. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00983.x · Cited by 108
Gottsäter, A., Landin-Olsson, M., Fernlund, P., Lernmark, Å., & Sundkvist, G. (1993) · Diabetes Care · doi:10.2337/diacare.16.6.902 · Cited by 107
Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes.
Zimmet, P., Turner, R. S., McCarty, D., Rowley, M., & Mackay, I. (1999) · PubMed · Cited by 105
Sj�berg, S., GUNNARSSON, R., Gj�tterberg, M., Lefvert, A., Persson, A., & �stman, J. (1987) · Diabetologia · doi:10.1007/bf00270417 · Cited by 101
Meta-Analysis of Nicotinamide Treatment in Patients With Recent-Onset IDDM
Pozzilli, P., Browne, P. D., Kolb, H., & Trialists, T. N. (1996) · Diabetes Care · doi:10.2337/diacare.19.12.1357 · Cited by 95
Self-citationMetformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes
Pagano, G., Tagliaferro, V., Carta, Q., Caselle, M. T., Bozzo, C., Vitelli, F., Trovati, M., & Cocuzza, E. (1983) · Diabetologia · doi:10.1007/bf00251823 · Cited by 94
Type 1 1/2 Diabetes: Myth or Reality?
Juneja, R., & Palmer, J. P. (1999) · Autoimmunity · doi:10.3109/08916939908995974 · Cited by 85
Insulin and Glucagon Secretion in Patients with Slowly Progressing Autoimmune Diabetes (LADA)1
Carlsson, Å., Sundkvist, G., Groop, L., & Tuomi, T. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6228 · Cited by 83
Distinct Genetic and Immunological Features in Patients With Onset of IDDM Before and After Age 40
Lohmann, T., Sessler, J., Verlohren, H.-J., Schröder, S., Rötger, J., Dãhn, K., Morgenthaler, N., & Scherbaum, W. A. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.524 · Cited by 81
Prigeon, R. L., Kahn, S. E., & Porte, D. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4641 · Cited by 79
Masuda, K., Okamoto, Y., Tsuura, Y., Kato, S., Miura, T., Tsuda, K., Horikoshi, H., Ishida, H., & Seino, Y. (1995) · Diabetologia · doi:10.1007/bf02369349 · Cited by 77
Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality.
Hawa, M., Fava, D., Medici, F., Deng, Y., Notkins, A. L., MATTIA, G. D., & Leslie, R. D. (2000) · Diabetes Care · doi:10.2337/diacare.23.2.228 · Cited by 77
Littorin, B., Sundkvist, G., Hagopian, W., Landin-Olsson, M., Lernmark, A., Ostman, J., Arnqvist, H. J., Blohmé, G., Bolinder, J., Eriksson, J. W., et al. (1999) · Diabetes Care · doi:10.2337/diacare.22.3.409 · Cited by 72
Klein, R., Klein, R., & Moss, S. E. (1995) · Diabetes · doi:10.2337/diab.44.7.796 · Cited by 72
Svejgaard, A., JAKOBSEN, B. K., Platz, P., et al. (1986) · Tissue Antigens · doi:10.1111/j.1399-0039.1986.tb00489.x · Cited by 71
T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report.
Shimada, A., Imazu, Y., Morinaga, S., Funae, O., Kasuga, A., Atsumi, Y., & Matsuoka, K. (1999) · Diabetes Care · doi:10.2337/diacare.22.4.615 · Cited by 64
Insulin and Glucagon Secretion in Patients with Slowly Progressing Autoimmune Diabetes (LADA)
Carlsson, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.76 · Cited by 63
Gender, Autoantibodies, and Obesity in Newly Diagnosed Diabetic Patients Aged 40–75 Years
Wroblewski, M., Gottsäter, A., Lindgärde, F., Fernlund, P., & Sundkvist, G. (1998) · Diabetes Care · doi:10.2337/diacare.21.2.250 · Cited by 61
Buzzetti, R., Quattrocchi, C. C., & Nisticò, L. (1998) · Diabetes/Metabolism Reviews · Cited by 61
Decochez, K., Keymeulen, B., Somers, G., Dorchy, H., De Leeuw, I. H., Mathieu, C., Rottiers, R., Winnock, F., ver Elst, K., Weets, I., et al. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1072 · Cited by 60
Immune abnormalities in diabetic patients not requiring insulin at diagnosis
Mario, U. D., Irvine, W. J., Borsey, D. Q., Kyner, J. L., Weston, J., & Galfo, C. (1983) · Diabetologia · doi:10.1007/bf00282516 · Cited by 58
Bosi, E., Garancini, M. P., Poggiali, F., Bonifacio, E. E., & Gallus, G. (1999) · Diabetologia · doi:10.1007/s001250051235 · Cited by 56
Glutamate decarboxylase antibody levels predict rate of β-cell decline in adult-onset diabetes
Gottsäter, A., Landin‐Olsson, M., Lernmark, Å., Fernlund, P., Sundkvist, G., & Hagopian, W. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01026-a · Cited by 54
Pozzilli, P., Visalli, N., Buzzetti, R., Cavallo, M. G., Marietti, G., Hawa, M. I., & Leslie, R. D. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90324-9 · Cited by 54
Self-citationPrigeon, R. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.819 · Cited by 51
Type I Diabetes Masquerading as Type II Diabetes: Possible implications for prevention and treatment
Leslie, R. D., & Pozzilli, P. (1994) · Diabetes Care · doi:10.2337/diacare.17.10.1214 · Cited by 48
Self-citationTroglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse
Beales, P. E., Liddi, R., Giorgini, A., Signore, A., Procaccini, E., Batchelor, K. W., & Pozzilli, P. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00574-3 · Cited by 47
Self-citationNakanishi, K., Kobayashi, T., Inoko, H., Tsuji, K., Murase, T., & Kosaka, K. (1995) · Diabetes · doi:10.2337/diab.44.11.1334 · Cited by 46
Kasuga, A., Maruyama, T., Ozawa, Y., Takei, I., Falorni, A., Lernmark, Å., & Saruta, T. (1996) · Journal of Autoimmunity · doi:10.1006/jaut.1996.0013 · Cited by 45
Seißler, J., Schott, M., Steinbrenner, H., Peterson, P., & Scherbaum, W. A. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212100 · Cited by 44
Ruige, J. B., Batstra, M. R., Aanstoot, H., Bouter, L. M., Bruining, G. J., de Neeling, J. N. D., & Heine, R. J. (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1108 · Cited by 42
Bruno, G., Salvia, A. D., Arcari, R., Borra, M., Grosso, N., Carta, Q., Trovati, M., Veglio, M., & Pagano, G. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.50 · Cited by 30
Schiel, R., & Müller, U. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00139-x · Cited by 27
Vauhkonen, I., NISKANEN, L. K., Knip, M., Uusitupa, M. I. J., Laakso, M., Ilonen, J., Kainulainen, S., & Vanninen, E. (2000) · Diabetologia · doi:10.1007/s001259900177 · Cited by 26
Nakanishi, K., Kobayashi, T., Inoko, H., et al. (1995) · Diabetes · doi:10.2337/diabetes.44.11.1334 · Cited by 21
Dowse, G. K., Zimmet, P. Z., Spark, R. A., Mavo, B., Rowley, M. J., & Mackay, I. R. (1994) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(94)90116-3 · Cited by 12
Modulation of antigen expression in relation to intervention strategies in type 1 diabetes
Mario, U. D., & Dotta, F. (1993) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610090404 · Cited by 6
The prevention of diabetes using rosiglitazone in the non-obese diabetic mouse
Beales, P. E., Rosignoli, G., Batchelor, K. W., et al. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)81324-8 · Cited by 2
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Type 2 diabetes: principles of pathogenesis and therapy
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
Diabetes mellitus: The epidemic of the century
Kharroubi, A. T. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.850 · Cited by 1,229
Sacks, D. B., Bruns, D. E., Goldstein, D. E., Maclaren, N. K., McDonald, J. M., & Parrott, M. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.436 · Cited by 1,130
Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
Metadata
- Authors
- Pozzilli, P., & Di Mario, U.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2001-08-01
- Volume
- 24
- Issue
- 8
- Pages
- 1460-1467
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2147139493
- Cited by
- 284
- References
- 64
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.